Chalcone compound applicable to hyperuricemia as well as preparation method and application of chalcone compound

By synthesizing novel structured chalkone compounds, the problem of insufficient inhibitory activity of xanthine oxidase in the existing gout drug toxic side effects is solved, and efficient inhibition of xanthine oxidase is achieved. The IC50 value is lower than that of the existing technology, which is suitable for Used for the treatment of hyperuricemia.

CN118955269APending Publication Date: 2024-11-15INSTITUTE OF BIOPHYSICS CHINESE ACADEMY OF SCIENCES
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411151679.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-21
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing gout drugs such as allopurinol and febuxstat have major toxic side effects, and their inhibitory activity on xanthine oxidase is insufficient, making it difficult to effectively reduce uric acid levels.

Method used

A class of novel structured Chalone compounds were designed and synthesized. Compounds with superior xanthine oxidase inhibitory activity were prepared through the reaction steps of Clayson-Schmitt condensation reaction and subsequent acidic conditions, with low IC50 values. Allopurinol in the prior art.

Benefits of technology

The high-efficiency inhibition of xanthine oxidase was achieved, with the IC50 value reaching 0.047±0.002 μmol/L, which is significantly better than existing drugs, has high xanthine oxidase inhibition activity, and is gentle in preparation, suitable for scale. Chemical production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118955269A_ABST
    Figure CN118955269A_ABST
Patent Text Reader

Abstract

The invention discloses a chalcone compound suitable for hyperuricemia as well as a preparation method and application of the chalcone compound. The invention belongs to the technical field of medicine, a chalcone compound with a novel structure is creatively designed and synthesized for the first time, and the chalcone compound is not reported in the field and existing literatures. The compounds have good xanthine oxidase inhibitory activity and are expected to be applied to preparation of drugs for treating hyperuricemia or gout. Structural general formula of chalcone compound disclosed by the invention is # imgabs0 #
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of medical technology, and specifically relates to a chalcone compound suitable for hyperuricemia and a preparation method and application thereof. Background Art

[0002] Gout is a crystal-related arthropathy caused by the deposition of monosodium urate (MSU), which is directly related to hyperuricemia caused by purine metabolism disorders and / or decreased uric acid excretion. The continuous increase of serum uric acid exceeding the solubility threshold causes urate crystals to deposit in joints and other soft tissues, which is the direct cause of gout. Gout attacks are often accompanied by unpredictable pain, joint swelling and redness, and joint damage caused by frequent attacks. In addition to the clinical symptoms it brings, gout is often accompanied by various serious complications, such as chronic kidney disease, abdominal obesity, hyperlipidemia, hypertension, type 2 diabetes and cardiovascular disease [Shi C, Zhou Z, Chi X, et al. Recent advances in gout drugs[J].European Journal of Medicinal Chemistry, 2023, 245: 114890.].

[0003] The level of uric acid in the body is closely related to the activity of xanthine oxidase. Xanthine oxidase can oxidize xanthine into hypoxanthine and then further oxidize it into uric acid. Therefore, xanthine oxidase is a good target for the treatment of hyperuricemia. Currently available gout drugs such as allopurinol and febuxostat belong to this type. However, these drugs all have significant toxic side effects. For example, common adverse reactions of allopurinol include gastrointestinal discomfort, allergic reactions, and rash [Pacher PAL, Nivorozhkin A, Szabó C. Therapeutic effects of xanthineoxidase inhibitors: renaissance half a century after the discovery of allopurinol[J]. Pharmacological reviews, 2006, 58(1): 87-114.]; and in another clinical comparative experiment, the all-cause mortality and cardiovascular disease mortality of febuxostat were higher than those of allopurinol [White WB, Saag KG, Becker MA, et al. Cardiovascular safety of febuxostat orallopurinol in patients with gout[J]. New England Journal of Medicine, 2018, 378(13): 1200-1210.]. Therefore, it is extremely necessary to develop highly effective and low-toxic xanthine oxidase inhibitors with new structures.

[0004] Chalcone is an aromatic ketone. It is a secondary metabolite produced by plants in the long-term natural selection process and is also a precursor of many flavonoids and isoflavonoids. As a flavonoid compound, it has almost no toxic side effects and is widely present in medicinal plants [Rozmer Z, Perjési P. Naturally occurring chalcones and their biological activities [J]. Phytochemistry reviews, 2016, 15: 87-120.]. Chalcone compounds have a wide spectrum of pharmacological activities, such as anti-tumor, antiviral, antibacterial, antimalarial, parasitic, anti-inflammatory, antioxidant, ulcer repair, immunomodulatory, hypoglycemic, and uric acid-lowering biological activities [Elkanzi NAA, Hrichi H, Alolayan RA, et al. Synthesis of chalcones derivatives and their biological activities: a review [J]. ACS omega, 2022, 7 (32): 27769-27786.]. Chalcone compounds are one of the hot topics in the development and utilization of natural medicines at home and abroad. In particular, in the past decade or so, research on their ability to inhibit xanthine oxidase activity has received increasing attention. Summary of the invention

[0005] The present invention aims at the deficiencies of the prior art and provides a chalcone compound suitable for hyperuricemia and a preparation method and application thereof. The chalcone compound of the present invention has excellent xanthine oxidase inhibitory activity, and its inhibitory effect is better than that of common hyperuricemia therapeutic drugs such as allopurinol.

[0006] In a first aspect, the present invention provides a chalcone compound suitable for treating hyperuricemia, using the following technical solution: The chalcone compounds suitable for hyperuricemia have the following general structural formula: ; Wherein, R1 is hydrogen, hydroxyl or halogen; R2 is hydroxyl or hydrogen; R3 is hydroxy or hydrogen; R4 is hydroxyl or hydrogen; R5 is hydroxy or hydrogen; R6 is methoxy, hydroxy, halogen, methyl or hydrogen; R7 is methoxy, hydroxy or hydrogen; R8 is methoxy, hydroxy, cyano or hydrogen; R9 is hydroxy or hydrogen; R10 is methoxy, hydroxy or hydrogen.

[0007] Furthermore, the general formula compound of the present invention is preferably the following specific compound:

[0008] In a second aspect, the present invention provides a method for synthesizing chalcone compounds suitable for hyperuricemia, using the following technical scheme: The synthesis method of chalcone compounds suitable for hyperuricemia comprises the following steps: Step 1) Add acetophenone derivatives containing different substituents or protecting groups, benzaldehyde derivatives containing different substituents or protecting groups, 95% ethanol and 50% potassium hydroxide (or inorganic strong bases such as sodium hydroxide and lithium hydroxide) in turn into an eggplant-shaped bottle, and stir the reaction at room temperature for 1-6 hours to produce a Claisen-Schmidt condensation reaction. After TLC monitoring of the reaction is complete, add an appropriate amount of ethyl acetate for extraction. Then, wash the ethyl acetate organic phase with water and saturated brine in turn, dry it with anhydrous sodium sulfate, spin dry it under reduced pressure, and separate it by silica gel column chromatography to obtain a chalcone with a protecting group and a parent core of 1,3-diphenyl-2-propene-1-one.

[0009] Step 2) Weigh an appropriate amount of the solid or oily compound obtained in step 1) and dissolve it in 95% ethanol (or isopropanol, n-butanol, tert-butanol, dichloromethane and other solvents), add an appropriate amount of 10% dilute HCl (or dilute H 2 SO 4 , p-toluenesulfonic acid, trifluoroacetic acid and other acids), react under heating conditions. After the reaction is completed by LCMS monitoring, the temperature of the reaction system is first lowered to room temperature, and then an appropriate amount of water is added to dilute the reaction system and extract with ethyl acetate. The ethyl acetate organic phase is then washed with water and saturated brine in sequence, dried over anhydrous sodium sulfate, dried under reduced pressure, and separated by silica gel column chromatography to obtain the chalcone target compound.

[0010] In a third aspect, the present invention provides use of chalcone compounds suitable for hyperuricemia in the preparation of drugs for preventing and treating hyperuricemia or gout.

[0011] The beneficial effects of the present invention are: 1) The present invention creatively designs and synthesizes a class of chalcone compounds with novel structures for the first time, which has not been reported in the art or existing literature.

[0012] 2) The present invention is 1 H-NMR and 13 The structures of the above-mentioned chalcone compounds were determined by characterization methods such as C-NMR, and the target molecules synthesized by the above-mentioned method are chalcone compounds.

[0013] 3) The preparation of the chalcone compounds in the present invention has the advantages of cheap and readily available starting materials, mild reaction conditions and high yield, simple post-treatment and purification operations, etc., which is conducive to large-scale industrial production.

[0014] 4) Most of the chalcone compounds designed and synthesized by the present invention have good xanthine oxidase inhibitory effects. 50 The inhibitory activity of xanthine oxidase was evaluated by the IC value. Compared with 12.3±0.2 μmol / L of allopurinol in the prior art, the IC value of the chalcone compounds in the present invention was 50 The lowest value reached 0.047±0.002μmol / L. DETAILED DESCRIPTION

[0015] The principles and features of the present invention are described below. The examples given are only used to explain the present invention and are not used to limit the scope of the present invention.

[0016] Unless otherwise specified, the raw materials described in the present invention can be obtained from public commercial channels unless otherwise specified. The experimental methods and detection methods in the following examples are conventional methods unless otherwise specified, and the instruments used in the experiments can be obtained from commercial channels.

[0017] The instruments used for characterization of the compounds of the present invention are: liquid chromatography-quadrupole-time of flight mass spectrometer Q-TOF Agilent 6530, Agilent nuclear magnetic resonance spectrometer DD2 500M and DD2 600M.

[0018] The instrument used for measuring the xanthine oxidase inhibitory activity of the compound of the present invention is a Puxi TU-1950 ultraviolet spectrophotometer.

[0019] For the compounds of the present invention, the xanthine oxidase used for determining the xanthine oxidase inhibitory activity was purchased from Shanghai MacLean Biochemical Technology Co., Ltd. with a product number of X902417-100U.

[0020] Example 1 Preparation of (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(3-hydroxyphenyl)prop-2-en-1-one: ; 1.1 Preparation of 1-(3-(methoxymethoxy)phenyl)ethan-1-one: ; Under nitrogen protection, 1-(3-hydroxyphenyl)ethane-1-one (1 g, 7.34 mmol), diisopropylethylamine (1.9 g, 14.7 mmol), and anhydrous tetrahydrofuran (15 mL) were added to a 100 mL eggplant-shaped bottle in sequence. After stirring for 5 minutes under ice bath conditions, bromomethyl methyl ether (1.38 g, 11.02 mmol) was slowly added. The reaction was carried out at room temperature for 2 hours, and the reaction of the raw materials was completed by TLC spot plate monitoring. Ethyl acetate (100 mL) was added, and the mixture was washed with water (50 mL X 3) and saturated brine (30 mL) in sequence, and dried over anhydrous sodium sulfate. After vacuum drying, the mixture was purified on a silica gel column (ethyl acetate: petroleum ether = 1:30 ~1:4) to obtain 1-(3-(methoxymethoxy)phenyl)ethane-1-one (1.1 g) with a yield of 83.1%. 1 H NMR (500 MHz, DMSO-d6) δ 7.59 (ddt,J = 7.7, 1.7, 0.8 Hz, 1H), 7.52 (t, J = 2.1 Hz, 1H), 7.43 (t, J = 7.9 Hz,1H), 7.32-7.21 (m, 1H), 5.23 (s, 2H), 3.37 (d, J = 0.8 Hz, 3H), 3.32 (s, 1H), 2.54 (d, J = 0.8 Hz, 3H). 1.2 Preparation of 2-methoxy-4-(methoxymethoxy)benzaldehyde: ; Under nitrogen protection, 4-hydroxy-2-methoxybenzaldehyde (1 g, 6.57 mmol), diisopropylethylamine (1.7 g, 13.2 mmol), and anhydrous tetrahydrofuran (15 mL) were added to a 100 mL eggplant-shaped bottle in sequence. After stirring for 5 minutes under ice bath conditions, bromomethyl methyl ether (1.23 g, 9.86 mmol) was slowly added. The reaction was carried out at room temperature for 2 hours, and the reaction of the raw materials was completed by TLC spot plate monitoring. Ethyl acetate (100 mL) was added, and the mixture was washed with water (50 mL X 3) and saturated brine (30 mL) in sequence, and dried over anhydrous sodium sulfate. After vacuum drying, it was purified on a silica gel column (ethyl acetate: petroleum ether = 1:30 ~1:4) to obtain a white solid 2-methoxy-4-(methoxymethoxy)benzaldehyde (1.04 g) with a yield of 80.6%. 1H NMR (500 MHz, DMSO-d6) δ10.17 (s, 1H), 7.65 (d, J = 8.6 Hz, 1H), 6.75 (d, J = 2.1 Hz, 1H), 6.70 (dd,J = 8.6, 2.2 Hz, 1H), 5.29 (s, 2H), 3.87 (s, 3H). 1.3 Preparation of (E)-3-(2-methoxy-4-(methoxymethoxy)phenyl)-1-(3-(methoxymethoxyphenyl)prop-2-en-1-one: ; Weigh 1-(3-(methoxymethoxy)phenyl)ethane-1-one (500 mg, 2.77 mmol) and 2-methoxy-4-(methoxymethoxy)benzaldehyde (545 mg, 2.77 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material reaction is complete. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-3-(2-methoxy-4-(methoxymethoxy)phenyl)-1-(3-(methoxymethoxyphenyl)prop-2-en-1-one (745 mg) with a yield of 74.9%. 1 H NMR (500MHz, DMSO-d6) δ 7.98 (dd, J = 15.8, 2.2 Hz, 1H), 7.93-7.86 (m, 1H), 7.78-7.69(m, 2H), 7.65 (d, J = 2.4 Hz, 1H), 7.46 (td, J = 8.4, 3.2 Hz, 1H), 7.27 (dd,J = 8.0, 3.1 Hz, 1H), 6.75-6.64 (m, 2H), 5.26 (t, J = 2.2 Hz, 4H), 3.87 (d, J= 3.7 Hz, 3H), 3.39 (d, J = 3.0 Hz, 6H). 13C NMR (126 MHz, DMSO-d6) δ 189.28,160.98, 160.25, 157.48, 139.91, 139.21, 130.52, 130.32, 122.29, 121.22,120.05, 117.23, 115.75, 108.54, 100.56, 94.39, 94.28, 56.31, 56.26, 56.11,40.29, 40.12, 39.95, 39.79, 39.62. 1.4 Preparation of (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(3-hydroxyphenyl)prop-2-en-1-one: ; (E)-3-(2-methoxy-4-(methoxymethoxy)phenyl)-1-(3-(methoxymethoxyphenyl)prop-2-en-1-one (400 mg, 1.12 mmol) was dissolved in 95% ethanol (15 mL). Then 10% HCl (3 mL) was added and the mixture was reacted at 60°C for 2 hours. The reaction was completed by TLC spot plate monitoring. Ethyl acetate (100 mL) was added and the mixture was washed with water (50 mL X 3) and saturated brine (30 mL) in sequence and dried over anhydrous sodium sulfate. After vacuum drying, the mixture was purified on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~1:1) to obtain a yellow solid (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(3-hydroxyphenyl)prop-2-en-1-one (170 mg) with a yield of 56.4%. 1 H NMR (500 MHz, DMSO-d6) δ 9.94 (s, 2H), 7.93 (d, J = 15.6 Hz,1H), 7.74 (d, J = 8.5 Hz, 1H), 7.58 (d, J = 15.7 Hz, 1H), 7.51 (d, J = 7.6Hz, 1H), 7.39 (t, J = 2.0 Hz, 1H), 7.32 (t, J = 7.8 Hz, 1H), 7.01 (dd, J =8.0, 2.5 Hz, 1H), 6.53-6.34 (m, 2H), 3.83 (s, 3H). 13C NMR (126 MHz, DMSO-d6) δ189.55, 162.33, 160.68, 158.08, 140.12, 139.62, 130.90, 130.17, 120.19,119.61, 118.69, 114.88, 114.86, 108.74, 99.54, 55.99. Example 2 Preparation of (E)-1-(2-fluoro-4-hydroxyphenyl)-3-(4-hydroxy-2-methoxyphenyl)prop-2-en-1-one: ; 2.1 Preparation of 1-(2-fluoro-4-(methoxymethoxy)phenyl)ethan-1-one: ; Weigh 1-(2-fluoro-4-hydroxyphenyl)ethan-1-one (1 g, 6.49 mmol), diisopropylethylamine (1.68 g, 12.98 mmol), and anhydrous tetrahydrofuran (15 mL) in sequence. After stirring for 5 minutes under ice bath conditions, slowly add bromomethyl methyl ether (1.22 g, 9.73 mmol). React at room temperature for 2 hours, and monitor the TLC spot plate. The raw material reacts completely. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:30 ~1:4) to obtain 1-(2-fluoro-4-(methoxymethoxy)phenyl)ethan-1-one (0.95 g), with a yield of 73.9%. 1 H NMR (600 MHz, DMSO-d6) δ 7.78 (t, J = 8.8 Hz, 1H), 7.02-6.81 (m, 2H), 5.27 (s, 2H), 3.36 (s, 3H), 2.49 (d, J = 4.5 Hz, 3H). 2.2 Preparation of (E)-1-(2-fluoro-4-(methoxymethoxy)phenyl)-3-(2-methoxy-4-(methoxymethoxy)phenyl)prop-2-en-1-one: ; Weigh 1-(2-fluoro-4-(methoxymethoxy)phenyl)ethan-1-one (500 mg, 2.52 mmol) and 2-methoxy-4-(methoxymethoxy)benzaldehyde (495 mg, 2.52 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material reaction is complete. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-1-(2-fluoro-4-(methoxymethoxy)phenyl)-3-(2-methoxy-4-(methoxymethoxy)phenyl)prop-2-en-1-one (619 mg) with a yield of 65.2%. 1 H NMR(500 MHz, DMSO-d6) δ 7.85 (dd, J = 15.8, 1.4 Hz, 1H), 7.77 (t, J = 8.9 Hz,1H), 7.67 (d, J = 8.6 Hz, 1H), 7.40 (dd, J = 15.8, 2.5 Hz, 1H), 7.00-6.95 (m,1H), 6.95 (s, 1H), 6.70 (d, J = 2.3 Hz, 1H), 6.66 (dd, J = 8.6, 2.3 Hz, 1H), 5.28 (s, 2H), 5.24 (s, 2H), 3.85 (s, 3H), 3.39 (s, 3H), 3.38 (s, 3H). 13 C NMR(126 MHz, DMSO-d6) δ 187.19, 187.16, 163.19, 161.62, 161.52, 161.18, 160.92,160.28, 138.99, 132.44, 132.41, 130.71, 123.80, 123.75, 120.93, 120.83,117.08, 112.93, 112.91, 108.52, 104.44, 104.23, 100.60, 94.42, 94.26, 56.37,56.24, 56.16. 2.3 Preparation of (E)-1-(2-fluoro-4-hydroxyphenyl)-3-(4-hydroxy-2-methoxyphenyl)prop-2-en-1-one: ; Weigh (E)-1-(2-fluoro-4-(methoxymethoxy)phenyl)-3-(2-methoxy-4-(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 1.06 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~ 1:1) to obtain a yellow solid (E)-1-(2-fluoro-4-hydroxyphenyl)-3-(4-hydroxy-2-methoxyphenyl)prop-2-en-1-one (142 mg) with a yield of 46.4%. 1 H NMR (600 MHz, DMSO-d6) δ 10.64 (s, 1H), 10.20 (s,1H), 7.80 (dd, J = 15.7, 1.7 Hz, 1H), 7.67 (t, J = 8.8 Hz, 1H), 7.55 (d, J =8.5 Hz, 1H), 7.31 (dd, J = 15.7, 2.4 Hz, 1H), 6.70 (dd, J = 8.6, 2.3 Hz, 1H), 6.62 (dd, J = 13.2, 2.2 Hz, 1H), 6.49-6.36 (m, 2H), 3.80 (s, 3H). 13 C NMR (126MHz, DMSO-d6) δ 186.80, 162.23, 160.64, 139.05, 132.76, 132.73, 130.94,122.44, 122.38, 114.70, 112.67, 108.77, 103.56, 103.36, 99.60, 55.97.19F NMR (470 MHz, DMSO-d6) δ -108.83. Example 3 Preparation of (E)-1-(3,5-dihydroxyphenyl)-3-(4-hydroxy-2-methoxyphenyl)prop-2-en-1-one: ; 3.1 Preparation of 1-(3,5-bis(methoxymethoxy)phenyl)ethan-1-one: ; Weigh 1-(3,5-dihydroxyphenyl)ethan-1-one (1 g, 6.57 mmol), diisopropylethylamine (3.4 g, 26.4 mmol), and anhydrous tetrahydrofuran (15 mL) in sequence. After stirring for 5 minutes under ice bath conditions, slowly add bromomethyl methyl ether (2.46 g, 19.7 mmol). React at room temperature for 2 hours, and monitor the reaction of the raw materials with TLC spot plate. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in sequence, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:30 ~1:4) to obtain 1-(3,5-bis(methoxymethoxy)phenyl)ethan-1-one (1.32 g), with a yield of 83.6%. 1 H NMR (500 MHz, DMSO-d6) δ 7.20 (s, 2H), 6.91 (s, 1H), 5.22 (s, 4H), 3.37 (s, 6H), 2.52 (s, 3H). 3.2 Preparation of (E)-1-(3,5-bis(methoxymethoxy)phenyl)-3-(2-methoxy-4-(methoxymethoxy)phenyl)prop-2-en-1-one: ; Weigh 1-(3,5-bis(methoxymethoxy)phenyl)ethan-1-one (500 mg, 2.08 mmol) and 2-methoxy-4-(methoxymethoxy)benzaldehyde (408 mg, 2.08 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material reaction is complete. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-1-(3,5-bis(methoxymethoxy)phenyl)-3-(2-methoxy-4-(methoxymethoxy)phenyl)prop-2-en-1-one (572 mg) with a yield of 65.7%. 1H NMR (500MHz, DMSO-d6) δ 7.97 (d, J = 15.7 Hz, 1H), 7.91 (d, J = 8.6 Hz, 1H), 7.67 (d,J = 15.7 Hz, 1H), 7.34 (d, J = 2.2 Hz, 2H), 6.92 (t, J = 2.2 Hz, 1H), 6.71(d, J = 2.3 Hz, 1H), 6.68 (dd, J = 8.6, 2.3 Hz, 1H), 5.26 (s, 2H), 5.25 (s,4H), 3.87 (s, 3H), 3.39 (s, 9H). 13 C NMR (126 MHz, DMSO-d6) δ 188.99, 161.02,160.26, 158.41, 140.57, 139.36, 130.55, 119.97, 117.19, 109.64, 109.29,108.55, 100.54, 94.52, 94.28, 56.31, 56.26, 56.21. 3.3 Preparation of (E)-1-(3,5-dihydroxyphenyl)-3-(4-hydroxy-2-methoxyphenyl)prop-2-en-1-one: ; Weigh (E)-1-(3,5-bis(methoxymethoxy)phenyl)-3-(2-methoxy-4-(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 0.96 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~ 1:1) to obtain a light yellow solid (E)-1-(3,5-dihydroxyphenyl)-3-(4-hydroxy-2-methoxyphenyl)prop-2-en-1-one (113 mg) with a yield of 41.3%. 1H NMR (500 MHz, DMSO-d6) δ 10.17 (s, 1H), 9.57 (s,2H), 7.87 (d, J = 15.6 Hz, 1H), 7.69 (d, J = 8.5 Hz, 1H), 7.48 (d, J = 15.6Hz, 1H), 6.87 (d, J = 2.2 Hz, 2H), 6.47-6.42 (m, 3H), 3.83 (s, 3H). 13 C NMR(126 MHz, DMSO-d6) δ 189.67, 162.22, 160.66, 159.05, 140.76, 139.57, 131.04,118.93, 114.87, 108.74, 107.11, 106.69, 99.56, 55.98. Example 4 Preparation of (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(2,3,4-trihydroxyphenyl)prop-2-en-1-one: ; 4.1 Preparation of 1-(2,3,4-tris(methoxymethoxy)phenyl)ethan-1-one: ; Under nitrogen protection, 1-(2,3,4-trihydroxyphenyl)ethan-1-one (1 g, 5.95 mmol) was weighed and dissolved in anhydrous N,N-dimethylformamide (15 mL). After stirring for 5 minutes under ice bath conditions, NaH (1.43 g, 35.7 mmol) was slowly added, and then bromomethyl methyl ether (3.34 g, 26.8 mmol) was added. The reaction was carried out at room temperature for 2 hours, and the reaction of the raw materials was completed by TLC spot plate monitoring. 2 mL of water was added under ice bath conditions to quench the reaction, and then ethyl acetate (100 mL) was added, and the mixture was washed with water (50 mL X3) and saturated brine (30 mL) in turn, and dried over anhydrous sodium sulfate. After vacuum drying, it was purified on a silica gel column (ethyl acetate: petroleum ether = 1:30 ~ 1:4) to obtain a colorless oil 1-(2,3,4-tri(methoxymethoxy)phenyl)ethan-1-one (1.42 g) with a yield of 79.5%. 1H NMR (500 MHz, DMSO-d6) δ 7.37 (d, J = 8.9 Hz, 1H), 6.97 (d, J = 8.8Hz, 1H), 5.26 (s, 2H), 5.09 (s, 2H), 5.08 (s, 2H), 3.50 (s, 3H), 3.39 (d, J =1.0 Hz, 6H), 2.52 (s, 3H). 4.2 Preparation of (E)-3-(2-methoxy-4-(methoxymethoxy)phenyl)-1-(2,3,4-tris(methoxymethoxy)phenyl)prop-2-en-1-one: ; Weigh 1-(2,3,4-tris(methoxymethoxy)phenyl)ethan-1-one (500 mg, 1.66 mmol) and 2-methoxy-4-(methoxymethoxy)benzaldehyde (327 mg, 1.66 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material reaction is complete. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-3-(2-methoxy-4-(methoxymethoxy)phenyl)-1-(2,3,4-tris(methoxymethoxy)phenyl)prop-2-en-1-one (461 mg) with a yield of 57.9%. 1 HNMR (500 MHz, DMSO-d6) δ 7.75 (d, J = 16.0 Hz, 1H), 7.67 (d, J = 8.6 Hz, 1H), 7.34 (d, J = 16.0 Hz, 1H), 7.28 (d, J = 8.7 Hz, 1H), 7.01 (d, J = 8.8 Hz,1H), 6.70 (d, J = 2.2 Hz, 1H), 6.67 (dd, J = 8.6, 2.3 Hz, 1H), 5.27 (s, 2H),5.25 (s, 2H), 5.12 (s, 2H), 5.03 (s, 2H), 3.83 (s, 3H), 3.53 (s, 3H), 3.41 (s, 3H), 3.38 (s, 3H), 3.31 (s, 3H). 13C NMR (126 MHz, DMSO-d6) δ 191.04,160.78, 160.08, 153.82, 150.02, 139.56, 138.25, 130.28, 129.19, 125.26,124.96, 117.14, 111.57, 108.61, 100.67, 99.96, 98.68, 94.92, 94.26, 57.45,57.21, 56.47, 56.29, 56.21. 4.3 Preparation of (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(2,3,4-trihydroxyphenyl)prop-2-en-1-one: ; Weigh (E)-3-(2-methoxy-4-(methoxymethoxy)phenyl)-1-(2,3,4-tri(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 0.84 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~ 1:1) to obtain an orange-red solid (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(2,3,4-trihydroxyphenyl)prop-2-en-1-one (67 mg) with a yield of 26.5%. 1 H NMR (500 MHz, DMSO-d6) δ 13.68 (s, 1H), 10.02(s, 1H), 8.05 (d, J = 15.4 Hz, 1H), 7.80 (d, J = 8.5 Hz, 1H), 7.69 (d, J =15.5 Hz, 1H), 7.61 (d, J = 8.9 Hz, 1H), 6.48-6.41 (m, 3H), 3.84 (s, 3H). 13 CNMR (126 MHz, DMSO-d6) δ 192.65, 162.54, 160.75, 154.02, 152.81, 139.25,132.89, 130.99, 122.49, 117.21, 114.85, 113.84, 108.81, 108.08, 99.52, 56.03. Example 5 Preparation of (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(2,4,6-trihydroxyphenyl)prop-2-en-1-one: ; 5.1 Preparation of 1-(2,4,6-tris(methoxymethoxy)phenyl)ethan-1-one: ; Under nitrogen protection, 1-(2,4,6-trihydroxyphenyl)ethan-1-one (1 g, 5.95 mmol) was weighed and dissolved in anhydrous N,N-dimethylformamide (15 mL). After stirring for 5 minutes under ice bath conditions, NaH (1.43 g, 35.7 mmol) was slowly added, and then bromomethyl methyl ether (3.34 g, 26.8 mmol) was added. The reaction was carried out at room temperature for 2 hours, and the reaction of the raw materials was completed by TLC spot plate monitoring. 2 mL of water was added to quench the reaction under ice bath conditions, and then ethyl acetate (100 mL) was added. The mixture was washed with water (50 mL X3) and saturated brine (30 mL) in turn, and dried over anhydrous sodium sulfate. After vacuum drying, it was purified on a silica gel column (ethyl acetate: petroleum ether = 1:30 ~ 1:4) to obtain a colorless oil 1-(2,4,6-tri(methoxymethoxy)phenyl)ethan-1-one (1.26 g) with a yield of 70.6%. 1 H NMR (500 MHz, DMSO-d6) δ 6.46 (s, 2H), 5.16 (s, 2H), 5.15 (s, 4H), 3.36 (s, 3H), 3.34 (s, 6H), 2.37 (s, 3H). 5.2 Preparation of (E)-3-(2-methoxy-4-(methoxymethoxy)phenyl)-1-(2,4,6-tris(methoxymethoxy)phenyl)prop-2-en-1-one: ; Weigh 1-(2,4,6-tris(methoxymethoxy)phenyl)ethan-1-one (500 mg, 1.66 mmol) and 2-methoxy-4-(methoxymethoxy)benzaldehyde (327 mg, 1.66 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material is completely reacted. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-3-(2-methoxy-4-(methoxymethoxy)phenyl)-1-(2,4,6-tris(methoxymethoxy)phenyl)prop-2-en-1-one (427 mg) with a yield of 53.6%. 1 HNMR (500 MHz, DMSO-d6) δ 7.75 (d, J = 16.0 Hz, 1H), 7.67 (d, J = 8.6 Hz, 1H), 7.34 (d, J = 15.9 Hz, 1H), 7.28 (d, J = 8.7 Hz, 1H), 7.01 (d, J = 8.7 Hz,1H), 6.70-6.65 (m, 2H), 5.27 (s, 2H), 5.25 (s, 2H), 5.12 (s, 2H), 5.03 (s,2H), 3.83 (s, 3H), 3.53 (s, 3H), 3.41 (s, 3H), 3.38 (s, 3H), 3.31 (s, 3H). 13 CNMR (126 MHz, DMSO-d6) δ 191.05, 160.78, 160.09, 153.82, 150.02, 139.56,138.26, 130.28, 129.19, 125.26, 124.97, 117.15, 111.57, 108.61, 100.67,99.96, 98.68, 94.92, 94.27, 57.45, 57.20, 56.47, 56.28, 56.21. 5.3 Preparation of (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(2,4,6-trihydroxyphenyl)prop-2-en-1-one: ; Weigh (E)-3-(2-methoxy-4-(methoxymethoxy)phenyl)-1-(2,4,6-tri(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 0.84 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~ 1:1) to obtain an orange-yellow solid (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(2,4,6-trihydroxyphenyl)prop-2-en-1-one (73 mg), with a yield of 28.9%. 1 H NMR (500 MHz, DMSO-d6) δ 12.52 (s, 2H), 10.32 (s, 1H), 10.13 (s, 1H), 8.03 (d, J = 15.6 Hz, 1H), 7.90 (d, J = 15.7 Hz, 1H), 7.44 (d, J = 8.4 Hz, 1H), 6.45 (s, 1H), 6.43 (dd, J = 8.4, 2.2 Hz, 1H), 5.81 (s, 2H), 3.81 (s, 3H). 13 C NMR (126 MHz, DMSO-d6) δ 192.45, 164.94, 164.82,161.96, 160.47, 137.94, 130.49, 124.13, 115.34, 108.79, 104.73, 99.65, 95.29,55.95. Example 6 Preparation of (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; 6.1 Preparation of 1-(3,4,5-tris(methoxymethoxy)phenyl)ethan-1-one: ; Under nitrogen protection, 1-(3,4,5-trimethoxyphenyl)ethan-1-one (10 g, 47.6 mmol) and anhydrous aluminum chloride (36.6 g, 285.6 mmol) were weighed and dissolved in toluene (200 mL). Refluxed at 120 degrees for 2 hours, and the reaction was complete by TLC spot plate monitoring. The reaction system was cooled to room temperature, and dilute hydrochloric acid (2 mol / L, 200 mL) was slowly added to the system under ice bath conditions. Then, dichloromethane (300 mL X 3) was used for extraction, and then ethyl acetate (300 mL X 3) was used for extraction. The ethyl acetate phase was combined, dried over anhydrous sodium sulfate, and the crude product (7.5 g) was obtained after spin drying. The obtained crude product (7.5 g) was dissolved in anhydrous tetrahydrofuran (150 mL), and then diisopropylethylamine (34.6 g, 26.8 mmol) and bromomethyl methyl ether (25.1 g, 200.7 mmol) were slowly added under ice bath conditions. The reaction was carried out at room temperature for 3 hours, and the reaction of the raw material was completed by TLC spot plate monitoring. Ethyl acetate (600 mL) was added, and the mixture was washed with water (300 mL X 3) and saturated brine (100 mL) in sequence, and dried over anhydrous sodium sulfate. After vacuum drying, the mixture was purified on a silica gel column (ethyl acetate: petroleum ether = 1:30 ~1:4) to obtain a colorless oily substance 1-(3,4,5-tris(methoxymethoxy)phenyl)ethan-1-one (12.1 g), and the two-step yield was 84.9%. 1 H NMR (500 MHz, DMSO-d6) δ 7.37 (s, 2H), 5.26 (s,4H), 5.13 (s, 2H), 3.49 (s, 3H), 3.40 (s, 6H), 2.51 (s, 3H). 13 C NMR (126 MHz, DMSO-d6) δ 196.93, 150.85, 140.92, 132.91, 110.30, 98.23, 95.25, 56.99,56.37, 26.93. 6.2 Preparation of (E)-3-(2-methoxy-4-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one: ; Weigh 1-(3,4,5-tris(methoxymethoxy)phenyl)ethan-1-one (500 mg, 1.66 mmol) and 2-methoxy-4-(methoxymethoxy)benzaldehyde (327 mg, 1.66 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material reacts completely. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain a light yellow oil (E)-3-(2-methoxy-4-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one (563 mg) with a yield of 70.7%. 1 H NMR (500 MHz, DMSO-d6) δ 7.95 (d, J = 15.6 Hz, 1H), 7.86 (d, J = 8.6Hz, 1H), 7.69 (d, J = 15.7 Hz, 1H), 7.51 (s, 2H), 6.75-6.65 (m, 2H), 5.31 (s, 4H), 5.26 (s, 2H), 5.16 (s, 2H), 3.88 (s, 3H), 3.52 (s, 3H), 3.43 (s, 6H), 3.39 (s, 3H). 13 C NMR (126 MHz, DMSO-d6) δ 188.30, 160.92, 160.27, 150.96,140.71, 139.16, 134.11, 130.71, 119.96, 117.26, 110.41, 108.53, 100.55,98.28, 95.30, 94.29, 56.99, 56.38, 56.28, 56.19. 6.3 Preparation of (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; Weigh (E)-3-(2-methoxy-4-(methoxymethoxy)phenyl)-1-(3,4,5-tri(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 0.84 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~ 1:1) to obtain a yellow solid (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one (137 mg) with a yield of 54.2%. 1 H NMR (500 MHz, DMSO-d6) δ 9.26 (s, 4H), 7.83 (d, J= 15.6 Hz, 1H), 7.67 (d, J = 8.4 Hz, 1H), 7.52 (d, J = 15.6 Hz, 1H), 7.08 (s,2H), 6.55-6.38 (m, 2H), 3.85 (s, 3H). 13 C NMR (126 MHz, DMSO-d6) δ 188.02,161.84, 160.45, 146.09, 138.92, 138.28, 130.82, 129.31, 118.86, 115.08,108.64, 108.36, 99.58, 55.97. Example 7 Preparation of (E)-3-(2-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; 7.1 Preparation of (E)-3-(2-methoxyphenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one: ; Weigh 1-(3,4,5-tris(methoxymethoxy)phenyl)ethan-1-one (500 mg, 1.66 mmol) and 2-methoxybenzaldehyde (227 mg, 1.66 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material reaction is complete. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-3-(2-methoxyphenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one (452 ​​mg) with a yield of 64.9%. 1H NMR (500 MHz, DMSO-d6) δ 8.00 (d,J = 15.7 Hz, 1H), 7.92 (dd, J = 7.7, 1.6 Hz, 1H), 7.79 (d, J = 15.8 Hz, 1H),7.52 (s, 2H), 7.44 (td, J = 8.0, 7.5, 1.7 Hz, 1H), 7.10 (d, J = 8.3 Hz, 1H), 7.03 (t, J = 7.5 Hz, 1H), 5.31 (s, 3H), 5.16 (s, 2H), 3.89 (s, 2H), 3.51 (s,2H), 3.43 (d, J = 1.1 Hz, 6H).13C NMR (126 MHz, DMSO-d6) δ 188.41, 158.75,150.99, 140.91, 139.09, 133.81, 132.75, 129.18, 123.35, 122.20, 121.11,112.25, 110.51, 98.29, 95.31, 57.01, 56.42, 56.12. 7.2 Preparation of (E)-3-(2-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; Weigh (E)-3-(2-methoxyphenyl)-1-(3,4,5-tri(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 0.96 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~1:1) to obtain a light yellow solid (E)-3-(2-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one (98 mg), with a yield of 35.8%. 1 H NMR (500 MHz, DMSO-d6) δ 9.23 (s, 3H), 7.89 (d, J = 15.7 Hz, 1H), 7.84 (dd, J = 7.8, 1.7 Hz, 1H), 7.69 (d, J = 15.6 Hz, 1H), 7.40 (ddd, J =8.7, 7.3, 1.6 Hz, 1H), 7.11 (s, 2H), 7.08 (d, J = 8.4 Hz, 1H), 7.00 (t, J =7.5 Hz, 1H), 3.88 (s, 3H). 13 C NMR (126 MHz, DMSO-d6) δ 188.06, 158.57, 146.16,139.35, 137.56, 132.25, 129.05, 128.86, 123.63, 122.69, 121.17, 112.21,108.57, 56.14. Example 8 Preparation of (E)-3-(4-hydroxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; 8.1 Preparation of 4-(methoxymethoxy)benzaldehyde: ; Weigh 4-hydroxybenzaldehyde (1 g, 8.19 mmol), diisopropylethylamine (2.12 g, 16.4 mmol), and anhydrous tetrahydrofuran (15 mL) in sequence. After stirring for 5 minutes under ice bath conditions, slowly add bromomethyl methyl ether (1.53 g, 12.3 mmol). React at room temperature for 2 hours, and monitor with TLC spot plate. The raw material reacts completely. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in sequence, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:30 ~1:4) to obtain 4-(methoxymethoxy)benzaldehyde (1.12 g), with a yield of 82.3%. 1 H NMR (500MHz, DMSO-d6) δ 9.87 (s, 1H), 7.98-7.72 (m, 2H), 7.32-7.03 (m, 2H), 5.29 (s,2H), 3.38 (s, 3H). 8.2 Preparation of (E)-3-(4-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one: ; Weigh 1-(3,4,5-tris(methoxymethoxy)phenyl)ethan-1-one (500 mg, 1.66 mmol) and 4-(methoxymethoxy)benzaldehyde (277 mg, 1.66 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material reacts completely. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-3-(4-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one (526 mg) with a yield of 70.4%. 1 H NMR (500 MHz, DMSO-d6)δ 7.87-7.78 (m, 2H), 7.69 (s, 2H), 7.52 (s, 1H), 7.13-7.05 (m, 2H), 5.31 (s,4H), 5.25 (s, 2H), 5.15 (s, 2H), 3.51 (s, 3H), 3.42 (s, 6H), 3.37 (s, 3H). 13CNMR (126 MHz, DMSO-d6) δ 188.19, 159.24, 150.92, 144.30, 140.91, 133.85,131.13, 128.68, 120.28, 116.77, 110.52, 98.28, 95.28, 94.15, 57.02, 56.45,56.20. 8.3 Preparation of (E)-3-(4-hydroxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; Weigh (E)-3-(4-(methoxymethoxy)phenyl)-1-(3,4,5-tri(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 0.89 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~1:1) to obtain a light yellow solid (E)-3-(4-hydroxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one (107 mg) with a yield of 44.1%. 1 H NMR (500 MHz, DMSO-d6) δ 9.98 (s, 1H), 9.12 (s, 3H), 7.67-7.60 (m,2H), 7.51 (q, J = 15.5 Hz, 2H), 7.09 (s, 2H), 6.85-6.75 (m, 2H). 13 C NMR (126MHz, DMSO-d6) δ 187.84, 160.17, 146.11, 143.19, 139.10, 130.96, 129.12,126.43, 119.14, 116.24, 108.52. Example 9 Preparation of (E)-3-(2,4-dimethoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; 9.1 Preparation of (E)-3-(2,4-dimethoxyphenyl)-1-(3,4,5-tri(methoxymethoxy)phenyl)prop-2-en-1-one: ; Weigh 1-(3,4,5-tris(methoxymethoxy)phenyl)ethan-1-one (500 mg, 1.66 mmol) and 2,4-dimethoxybenzaldehyde (277 mg, 1.66 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material is completely reacted. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-3-(2,4-dimethoxyphenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one (478 mg) with a yield of 64.0%. 1 H NMR (500 MHz, DMSO-d6) δ7.94 (d, J = 15.6 Hz, 1H), 7.86 (dd, J = 8.9, 3.6 Hz, 1H), 7.66 (dd, J =15.8, 2.2 Hz, 1H), 7.49 (d, J = 1.6 Hz, 2H), 6.71-6.55 (m, 2H), 5.30 (t, J =2.6 Hz, 4H), 5.15 (d, J = 2.0 Hz, 2H), 3.89 (q, J = 3.6, 2.7 Hz, 3H), 3.83(d, J = 3.3 Hz, 3H), 3.54-3.48 (m, 3H), 3.46-3.39 (m, 6H). 13 C NMR (126 MHz, DMSO-d6) δ 188.25, 163.55, 160.47, 150.94, 140.66, 139.33, 134.15, 130.84,119.41, 116.33, 110.37, 106.83, 98.73, 98.27, 95.30, 57.01, 56.41, 56.24,56.00, 55.98. 9.2 Preparation of (E)-3-(2,4-dimethoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; Weigh (E)-3-(2,4-dimethoxyphenyl)-1-(3,4,5-tri(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 0.89 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~1:1) to obtain a yellow solid (E)-3-(2,4-dimethoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one (117 mg) with a yield of 41.5%. 1 H NMR (500 MHz, DMSO-d6) δ 9.19 (s, 2H), 7.82 (d, J = 15.7 Hz,1H), 7.78 (d, J = 8.6 Hz, 1H), 7.57 (d, J = 15.7 Hz, 1H), 7.07 (s, 2H), 6.66– 6.52 (m, 2H), 3.89 (s, 3H), 3.81 (s, 3H). 13 C NMR (126 MHz, DMSO-d6) δ188.02, 163.09, 160.20, 146.12, 139.05, 137.81, 130.63, 129.18, 119.95,116.62, 108.44, 106.65, 98.83, 56.24, 55.93. Example 10 Preparation of (E)-1-(3,4,5-trihydroxyphenyl)-3-(2,4,6-trimethoxyphenyl)prop-2-en-1-one: ; 10.1 Preparation of (E)-3-(2,4,6-trimethoxyphenyl)-1-(3,4,5-tri(methoxymethoxy)phenyl)prop-2-en-1-one: ; Weigh 1-(3,4,5-tris(methoxymethoxy)phenyl)ethan-1-one (500 mg, 1.66 mmol) and 2,4,6-trimethoxybenzaldehyde (327 mg, 1.66 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material reaction is complete. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-3-(2,4,6-trimethoxyphenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one (622 mg) with a yield of 78.1%. 1 H NMR (600 MHz, DMSO-d6) δ8.03 (d, J = 15.7 Hz, 1H), 7.84 (d, J = 15.7 Hz, 1H), 7.42 (s, 2H), 6.29 (s,2H), 5.27 (s, 4H), 5.13 (s, 2H), 3.89 (s, 6H), 3.83 (s, 3H), 3.49 (s, 3H), 3.42 (s, 6H). 13 C NMR (151 MHz, DMSO-d6) δ 188.94, 163.80, 161.84, 151.04,140.09, 135.44, 134.58, 120.52, 109.95, 105.49, 98.20, 95.29, 91.49, 56.98,56.41, 56.31, 56.01. 10.2 Preparation of (E)-3-(2,4-dimethoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; Weigh (E)-3-(2,4,6-trimethoxyphenyl)-1-(3,4,5-tri(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 0.84 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in sequence, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~1:1) to obtain an orange-yellow solid (E)-3-(2,4-dimethoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one (141 mg) with a yield of 48.7%. 1 H NMR (600 MHz, DMSO-d6) δ 9.16 (s, 3H), 7.94 (d, J = 15.7 Hz,1H), 7.76 (d, J = 15.7 Hz, 1H), 6.98 (s, 2H), 6.29 (s, 2H), 3.89 (s, 6H),3.82 (s, 3H). 13 C NMR (126 MHz, DMSO-d6) δ 188.66, 170.77, 163.31, 161.58,158.38, 146.10, 145.74, 138.76, 133.90, 129.47, 121.01, 108.05, 105.72,91.51, 60.19, 56.50, 55.97. Example 11 Preparation of (E)-3-(4-hydroxy-2-methylphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; 11.1 Preparation of 4-(methoxymethoxy)-2-methylbenzaldehyde: ; Weigh 4-hydroxy-2-methylbenzaldehyde (1 g, 7.34 mmol), diisopropylethylamine (1.88 g, 14.54 mmol), and anhydrous tetrahydrofuran (15 mL) in sequence. After stirring for 5 minutes under ice bath conditions, slowly add bromomethyl methyl ether (1.36 g, 10.9 mmol). React at room temperature for 2 hours, and monitor the TLC spot plate. The raw material reacts completely. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:30 ~1:4) to obtain 4-(methoxymethoxy)-2-methylbenzaldehyde (1.1 g), with a yield of 83.9%. 1 H NMR (500 MHz, DMSO-d6) δ 10.06 (s, 1H), 7.75 (d, J = 8.5 Hz, 1H), 7.00(dd, J = 8.6, 2.5 Hz, 1H), 6.96-6.88 (m, 1H), 5.27 (s, 2H), 3.37 (s, 3H),2.56 (s, 3H). 11.2 Preparation of (E)-3-(4-(methoxymethoxy)-2-methylphenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one: ; Weigh 1-(3,4,5-tris(methoxymethoxy)phenyl)ethan-1-one (500 mg, 1.66 mmol) and 4-(methoxymethoxy)-2-methylbenzaldehyde (300 mg, 1.66 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material reaction is complete. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-3-(4-(methoxymethoxy)-2-methylphenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one (418 mg) with a yield of 54.3%. 1H NMR(500 MHz, DMSO-d6) δ 7.98-7.86 (m, 2H), 7.60 (d, J = 15.4 Hz, 1H), 7.52 (s,2H), 7.00-6.87 (m, 2H), 5.31 (s, 4H), 5.23 (s, 2H), 5.15 (s, 2H), 3.51 (s,3H), 3.42 (s, 6H), 3.37 (s, 3H), 2.40 (s, 3H). 13 C NMR (126 MHz, DMSO-d6) δ188.33, 158.90, 150.93, 141.21, 140.87, 140.68, 133.89, 129.06, 127.25,121.20, 118.24, 114.59, 110.52, 98.28, 95.28, 94.00, 57.02, 56.44, 56.14,19.93. 11.3 Preparation of (E)-3-(4-hydroxy-2-methylphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; Weigh (E)-3-(4-(methoxymethoxy)-2-methylphenyl)-1-(3,4,5-tri(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 0.86 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~ 1:1) to obtain a yellow solid (E)-3-(4-hydroxy-2-methylphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one (95 mg) with a yield of 38.4%. 1 H NMR (500 MHz, DMSO-d6) δ 9.86 (s, 1H), 9.19 (s, 3H), 7.89-7.72 (m, 2H), 7.42 (d, J = 15.4 Hz, 1H), 7.09 (s, 2H), 6.66 (d, J = 6.4Hz, 2H), 2.34 (s, 3H). 13C NMR (126 MHz, DMSO-d6) δ 187.82, 159.83, 146.11,140.45, 140.11, 139.10, 129.11, 128.95, 124.94, 119.82, 117.75, 114.22,108.49, 19.97. Example 12 Preparation of (E)-3-(2-chloro-4-hydroxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; 12.1 Preparation of 2-chloro-4-(methoxymethoxy)benzaldehyde: : Weigh 2-chloro-4-hydroxybenzaldehyde (1 g, 6.39 mmol), diisopropylethylamine (1.65 g, 12.77 mmol), and anhydrous tetrahydrofuran (15 mL) in sequence. After stirring for 5 minutes under ice bath conditions, slowly add bromomethyl methyl ether (1.2 g, 9.58 mmol). React at room temperature for 2 hours, and monitor the TLC plate. The raw material reacts completely. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:30 ~1:4) to obtain 2-chloro-4-(methoxymethoxy)benzaldehyde (1.03 g), with a yield of 80.4%. 1 HNMR (500 MHz, DMSO-d6) δ 10.18 (d, J = 0.8 Hz, 1H), 7.81 (d, J = 8.7 Hz, 1H), 7.20 (d, J = 2.4 Hz, 1H), 7.12 (ddd, J = 8.7, 2.4, 0.8 Hz, 1H), 5.32 (s, 2H),3.38 (s, 3H). 12.2 Preparation of (E)-3-(2-chloro-4-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one: : Weigh 1-(3,4,5-tris(methoxymethoxy)phenyl)ethan-1-one (500 mg, 1.66 mmol) and 2-chloro-4-hydroxybenzaldehyde (334 mg, 1.66 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material reacts completely. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-3-(2-chloro-4-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one (517 mg) with a yield of 64.3%. 1 H NMR (500 MHz, DMSO-d6)δ 8.13 (d, J = 8.8 Hz, 1H), 7.96 (d, J = 15.5 Hz, 1H), 7.77 (d, J = 15.5 Hz,1H), 7.54 (s, 2H), 7.22 (d, J = 2.5 Hz, 1H), 7.10 (dd, J = 8.8, 2.5 Hz, 1H), 5.31 (s, 4H), 5.28 (s, 2H), 5.16 (s, 2H), 3.51 (s, 3H), 3.42 (s, 6H), 3.38(s, 3H). 13 C NMR (126 MHz, DMSO-d6) δ 188.08, 159.43, 150.96, 141.17, 138.82,135.93, 133.53, 130.11, 126.03, 122.96, 117.28, 116.41, 110.69, 98.30, 95.31,94.41, 57.02, 56.46, 56.38. 12.3 Preparation of (E)-3-(2-chloro-4-hydroxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; Weigh (E)-3-(2-chloro-4-(methoxymethoxy)phenyl)-1-(3,4,5-tri(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 0.83 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10~1:1) to obtain a light yellow-brown solid (E)-3-(2-chloro-4-hydroxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one (86 mg) with a yield of 33.9%. 1 H NMR (500 MHz, DMSO-d6) δ 10.45 (s, 1H), 9.21 (s, 3H), 7.98 (d, J = 8.7 Hz, 1H), 7.86 (d, J = 15.3 Hz, 1H), 7.59 (d, J = 15.5 Hz, 1H), 7.11 (s, 2H), 7.01-6.68 (m, 2H). 13 C NMR (126 MHz, DMSO-d6) δ 187.78,158.20, 146.21, 139.75, 135.30, 132.08, 129.71, 129.13, 128.65, 128.51,125.96, 124.99, 119.05, 115.67, 113.50, 108.80. Example 13 Preparation of (E)-3-methoxy-4-(3-oxo-3-(3,4,5-trihydroxyphenyl)prop-1-en-1-yl)benzonitrile: ; 13.1 Preparation of (E)-3-methoxy-4-(3-oxo-3-(3,4,5-tri(methoxymethoxy)phenyl)prop-1-en-1-yl)benzonitrile: ; Weigh 1-(3,4,5-tris(methoxymethoxy)phenyl)ethan-1-one (500 mg, 1.66 mmol) and 4-formyl-3-methoxybenzonitrile (268 mg, 1.66 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material is completely reacted. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-3-methoxy-4-(3-oxo-3-(3,4,5-tris(methoxymethoxy)phenyl)prop-1-en-1-yl)benzonitrile (537 mg) with a yield of 72.7%. 1 H NMR (500 MHz, DMSO-d6)δ 8.11 (d, J = 8.0 Hz, 1H), 7.93 (s, 2H), 7.59 (d, J = 1.5 Hz, 1H), 7.53 (s,2H), 7.50 (dd, J = 8.0, 1.5 Hz, 1H), 5.31 (s, 4H), 5.16 (s, 2H), 3.94 (s,3H), 3.51 (s, 3H), 3.42 (s, 6H). 13 C NMR (126 MHz, DMSO-d6) δ 188.18, 158.35,151.01, 141.24, 136.81, 133.37, 129.80, 128.27, 125.34, 124.92, 118.99,115.77, 113.96, 110.68, 98.29, 95.31, 57.03, 56.89, 56.46. 13.2 Preparation of (E)-3-methoxy-4-(3-oxo-3-(3,4,5-trihydroxyphenyl)prop-1-en-1-yl)benzonitrile: ; Weigh (E)-3-methoxy-4-(3-oxo-3-(3,4,5-tri(methoxymethoxy)phenyl)prop-1-en-1-yl)benzonitrile (400 mg, 0.902 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~1:1) to obtain an orange solid (E)-3-methoxy-4-(3-oxo-3-(3,4,5-trihydroxyphenyl)prop-1-en-1-yl)benzonitrile (129 mg) with a yield of 45.9%. 1 H NMR (500 MHz, DMSO-d6) δ 9.25 (s, 3H), 8.07 (d, J =8.0 Hz, 1H), 7.83 (d, J = 3.3 Hz, 2H), 7.57 (s, 1H), 7.46 (d, J = 7.9 Hz,1H), 7.12 (s, 2H), 3.94 (s, 3H). 13 C NMR (126 MHz, DMSO-d6) δ 187.78, 158.20,146.21, 139.74, 135.30, 132.07, 129.71, 129.12, 128.65, 128.52, 125.96,124.99, 119.04, 115.66, 113.50, 108.80, 56.87. Example 14 Preparation of (E)-3-(3-hydroxy-2-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; 14.1 Preparation of 2-methoxy-3-(methoxymethoxy)benzaldehyde: ; Weigh 3-hydroxy-2-methoxybenzaldehyde (1 g, 6.57 mmol), diisopropylethylamine (1.7 g, 13.15 mmol), and anhydrous tetrahydrofuran (15 mL) in sequence. Stir in an ice bath for 5 minutes, then slowly add bromomethyl methyl ether (1.23 g, 9.86 mmol). React at room temperature for 2 hours, and monitor with TLC spot plate. The raw material reacts completely. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in sequence, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:30 ~1:4) to obtain 2-methoxy-3-(methoxymethoxy)benzaldehyde (1.06 g), with a yield of 82.2%. 1 H NMR (500 MHz, DMSO-d6) δ 10.29 (s, 1H), 7.44 (dd, J = 8.2, 1.7 Hz, 1H), 7.33 (dd, J = 7.9, 1.7 Hz, 1H), 7.18 (t, J = 8.0 Hz, 1H), 5.28 (s, 2H), 3.93 (s, 3H), 3.42 (s, 3H). 14.2 Preparation of (E)-3-(2-methoxy-3-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one: ; Weigh 1-(3,4,5-tris(methoxymethoxy)phenyl)ethan-1-one (500 mg, 1.66 mmol) and 2-methoxy-3-(methoxymethoxy)benzaldehyde (326 mg, 1.66 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material reaction is complete. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-3-(2-methoxy-3-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one (561 mg) with a yield of 70.4%. 1HNMR (500 MHz, DMSO-d6) δ 7.94 (d, J = 15.7 Hz, 1H), 7.81 (d, J = 15.9 Hz,1H), 7.63 (dd, J = 7.9, 1.5 Hz, 1H), 7.54 (s, 2H), 7.23 (dd, J = 8.2, 1.5 Hz,1H), 7.13 (t, J = 8.0 Hz, 1H), 5.31 (s, 4H), 5.25 (s, 2H), 5.16 (s, 2H), 3.83(s, 3H), 3.51 (s, 3H), 3.42 (d, J = 2.1 Hz, 9H). 13 C NMR (126 MHz, DMSO-d6) δ 188.38, 150.99, 150.58, 149.56, 141.06,138.46, 133.65, 129.04, 124.66, 123.33, 121.34, 119.15, 110.58, 98.29, 95.32,95.00, 61.57, 60.18, 57.02, 56.44, 56.34. 14.3 Preparation of (E)-3-(3-hydroxy-2-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; Weigh (E)-3-(2-methoxy-3-(methoxymethoxy)phenyl)-1-(3,4,5-tri(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 0.836 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~1:1) to obtain a yellow-green solid (E)-3-(3-hydroxy-2-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one (115 mg) with a yield of 45.5%. 1H NMR (500 MHz, DMSO-d6) δ 9.54 (s, 1H), 9.22(s, 3H), 7.81 (d, J = 15.7 Hz, 1H), 7.66 (d, J = 15.7 Hz, 1H), 7.33 (dd, J =7.7, 1.7 Hz, 1H), 7.10 (s, 2H), 7.07-6.80 (m, 2H), 3.77 (s, 3H). 13 C NMR (126MHz, DMSO-d6) δ 188.04, 150.99, 147.56, 146.18, 139.42, 137.50, 129.01,128.81, 124.73, 123.21, 119.09, 118.56, 108.61, 61.00, 60.19. Example 15 Preparation of (E)-3-(5-hydroxy-2-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; 15.1 Preparation of 2-methoxy-5-(methoxymethoxy)benzaldehyde: : Weigh 5-hydroxy-2-methoxybenzaldehyde (1 g, 6.57 mmol), diisopropylethylamine (1.7 g, 13.15 mmol), and anhydrous tetrahydrofuran (15 mL) in sequence. After stirring for 5 minutes under ice bath conditions, slowly add bromomethyl methyl ether (1.23 g, 9.86 mmol). React at room temperature for 2 hours, and monitor with TLC spot plate. The raw material reacts completely. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in sequence, and dry over anhydrous sodium sulfate. After vacuum spin drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:30 ~1:4) to obtain 2-methoxy-5-(methoxymethoxy)benzaldehyde (986 mg), with a yield of 76.5%. 1 H NMR (500 MHz, DMSO-d6) δ 10.30 (s, 1H), 7.32 (dd, J = 9.0, 3.1 Hz,1H), 7.29 (d, J = 3.1 Hz, 1H), 7.18 (d, J = 8.9 Hz, 1H), 5.14 (s, 2H), 3.86(s, 3H), 3.35(s, 3H). 15.2 Preparation of (E)-3-(2-methoxy-5-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one: ; Weigh 1-(3,4,5-tris(methoxymethoxy)phenyl)ethan-1-one (500 mg, 1.66 mmol) and 2-methoxy-5-(methoxymethoxy)benzaldehyde (326 mg, 1.66 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material reaction is complete. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-3-(2-methoxy-5-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one (437 mg) with a yield of 54.9%. 1 HNMR (500 MHz, DMSO-d6) δ 7.94 (d, J = 15.7 Hz, 1H), 7.76 (d, J = 15.7 Hz,1H), 7.57 (d, J = 2.9 Hz, 1H), 7.51 (s, 2H), 7.13 (dd, J = 9.0, 2.9 Hz, 1H), 7.04 (d, J = 9.1 Hz, 1H), 5.31 (s, 4H), 5.16 (d, J = 8.5 Hz, 4H), 3.84 (s, 3H), 3.51 (s, 3H), 3.42 (s, 6H), 3.38 (s, 3H). 13 C NMR (126 MHz, DMSO-d6) δ188.44, 153.98, 150.99, 150.94, 140.99, 138.71, 133.77, 124.01, 122.66,120.54, 116.88, 113.25, 110.63, 98.30, 95.34, 94.98, 57.01, 56.47, 56.41,55.95. 15.3 Preparation of (E)-3-(5-hydroxy-2-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; Weigh (E)-3-(2-methoxy-5-(methoxymethoxy)phenyl)-1-(3,4,5-tri(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 0.836 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~ 1:1) to obtain a yellow solid (E)-3-(5-hydroxy-2-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one (92 mg) with a yield of 36.4%. 1 H NMR (500 MHz, DMSO-d6) δ 9.16 (s, 4H), 7.80 (d, J= 15.7 Hz, 1H), 7.55 (d, J = 15.7 Hz, 1H), 7.17 (d, J = 2.9 Hz, 1H), 7.06 (s,2H), 6.92 (d, J = 8.9 Hz, 1H), 6.83 (dd, J = 8.9, 2.9 Hz, 1H), 3.79 (s, 3H). 13 C NMR (126 MHz, DMSO-d6) δ 187.95, 152.00, 151.54, 146.17, 139.32, 137.60,128.86, 124.19, 122.42, 118.99, 114.50, 113.54, 108.49, 60.19, 56.55. Example 16 Preparation of (E)-3-(2-hydroxy-6-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; 16.1 Preparation of 2-methoxy-6-(methoxymethoxy)benzaldehyde ; Weigh 2-hydroxy-6-methoxybenzaldehyde (1 g, 6.57 mmol), diisopropylethylamine (1.7 g, 13.15mmol), and anhydrous tetrahydrofuran (15 mL) in sequence. After stirring for 5 minutes under ice bath conditions, slowly add bromomethyl methyl ether (1.23 g, 9.86 mmol). React at room temperature for 2 hours, and monitor with TLC spot plate. The raw material reacts completely. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in sequence, and dry over anhydrous sodium sulfate. After vacuum spin drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:30 ~1:4) to obtain 2-methoxy-6-(methoxymethoxy)benzaldehyde (768 mg), with a yield of 59.6%. 1 H NMR (500 MHz, DMSO-d6) δ 10.37 (s, 1H), 7.50 (t, J = 8.5 Hz, 1H), 6.78 (dd, J = 8.5, 6.1 Hz, 2H), 5.24 (s, 2H), 3.81 (s, 3H), 3.37 (s, 3H). 16.2 Preparation of (E)-3-(2-methoxy-6-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one: ; Weigh 1-(3,4,5-tris(methoxymethoxy)phenyl)ethan-1-one (500 mg, 1.66 mmol) and 2-methoxy-6-(methoxymethoxy)benzaldehyde (326 mg, 1.66 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material reaction is complete. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-3-(2-methoxy-6-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one (419 mg) with a yield of 52.6%. 1HNMR (500 MHz, DMSO-d6) δ 8.20-7.89 (m, 2H), 7.46 (s, 2H), 7.35 (t, J = 8.4Hz, 1H), 6.83-6.75 (m, 2H), 5.34 (s, 2H), 5.29 (s, 4H), 5.15 (s, 2H), 3.90 (s, 3H), 3.51 (s, 3H), 3.43 (s, 6H), 3.41 (s, 3H). 13 C NMR (126 MHz, DMSO-d6) δ189.08, 160.39, 157.83, 151.12, 140.44, 135.06, 134.15, 132.55, 124.26,112.98, 110.06, 107.57, 105.46, 98.24, 95.29, 94.84, 57.01, 56.46, 56.43,56.34. 16.3 Preparation of (E)-3-(2-hydroxy-6-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; Weigh (E)-3-(2-methoxy-6-(methoxymethoxy)phenyl)-1-(3,4,5-tri(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 0.836 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~ 1:1) to obtain a gray-brown solid (E)-3-(2-hydroxy-6-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one (69 mg) with a yield of 27.3%. 1 H NMR (500 MHz, DMSO-d6) δ 10.34 (s, 1H), 9.26 (s, 2H), 9.01 (s, 1H), 8.13-7.86 (m, 2H), 7.17 (t, J = 8.3 Hz, 1H), 7.00 (s,2H), 6.65-6.45 (m, 2H), 3.86 (s, 3H). 13C NMR (126 MHz, DMSO-d6) δ 188.88,160.45, 159.12, 146.14, 138.96, 134.48, 131.90, 129.33, 123.43, 111.18,109.15, 108.16, 102.64, 56.28. Example 17 Preparation of (E)-3-(4-hydroxy-3-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; 17.1 Preparation of 3-methoxy-4-(methoxymethoxy)benzaldehyde: ; Weigh 4-hydroxy-3-methoxybenzaldehyde (1 g, 6.57 mmol), diisopropylethylamine (1.7 g, 13.15 mmol), and anhydrous tetrahydrofuran (15 mL) in sequence. After stirring for 5 minutes under ice bath conditions, slowly add bromomethyl methyl ether (1.23 g, 9.86 mmol). React at room temperature for 2 hours, and monitor with TLC spot plate. The raw material reacts completely. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in sequence, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:30 ~1:4) to obtain 3-methoxy-4-(methoxymethoxy)benzaldehyde (1.07 g), with a yield of 83.0%. 1 H NMR (500 MHz, DMSO-d6) δ 9.84 (s, 1H), 7.50 (dd, J = 8.2, 1.9 Hz,1H), 7.43 (d, J = 1.9 Hz, 1H), 7.24 (d, J = 8.2 Hz, 1H), 5.28 (s, 2H), 3.84(s, 3H), 3.38(s, 3H). 17.2 Preparation of (E)-3-(3-methoxy-4-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one: ; Weigh 1-(3,4,5-tris(methoxymethoxy)phenyl)ethan-1-one (500 mg, 1.66 mmol) and 3-methoxy-4-(methoxymethoxy)benzaldehyde (326 mg, 1.66 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material reaction is complete. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-3-(3-methoxy-4-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one (624 mg) with a yield of 78.3%. 1 HNMR (500 MHz, DMSO-d6) δ 7.68 (d, J = 2.1 Hz, 2H), 7.50 (d, J = 11.6 Hz, 3H), 7.40 (dd, J = 8.4, 2.0 Hz, 1H), 7.11 (d, J = 8.4 Hz, 1H), 5.31 (s, 4H), 5.22(s, 2H), 5.16 (s, 2H), 3.85 (s, 3H), 3.51 (s, 3H), 3.42 (s, 6H), 3.38 (s,3H). 13 C NMR (126 MHz, DMSO-d6) δ 188.39, 150.91, 150.27, 148.72, 144.71,140.98, 133.89, 129.41, 123.10, 120.81, 116.53, 112.90, 110.71, 98.30, 95.34,95.02, 57.03, 56.46, 56.30. 17.3 Preparation of (E)-3-(4-hydroxy-3-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; Weigh (E)-3-(3-methoxy-4-(methoxymethoxy)phenyl)-1-(3,4,5-tri(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 0.836 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~ 1:1) to obtain a yellow solid (E)-3-(4-hydroxy-3-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one (125 mg) with a yield of 49.5%. 1 H NMR (500 MHz, DMSO-d6) δ 9.57 (s, 1H), 9.18 (d, J= 16.1 Hz, 3H), 7.54 (s, 2H), 7.43 (d, J = 1.9 Hz, 1H), 7.19 (d, J = 8.1 Hz,1H), 7.12 (s, 2H), 6.80 (d, J = 8.1 Hz, 1H), 3.85 (s, 3H). 13 C NMR (126 MHz, DMSO-d6) δ 187.90, 149.72, 148.40, 146.09, 143.65, 139.10, 129.17, 126.95, 124.01, 119.37, 116.02, 111.85, 108.61, 56.23, 40.46, 40.30, 40.13, 39.96,39.79, 39.63, 39.46. Example 18 Preparation of (E)-3-(3-hydroxy-5-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; 18.1 Preparation of 3-methoxy-5-(methoxymethoxy)benzaldehyde: ; Weigh 3-hydroxy-5-methoxybenzaldehyde (1 g, 6.57 mmol), diisopropylethylamine (1.7 g, 13.15 mmol), and anhydrous tetrahydrofuran (15 mL) in sequence. After stirring for 5 minutes under ice bath conditions, slowly add bromomethyl methyl ether (1.23 g, 9.86 mmol). React at room temperature for 2 hours, and monitor with TLC spot plate. The raw material reacts completely. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in sequence, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:30 ~1:4) to obtain 3-methoxy-5-(methoxymethoxy)benzaldehyde (1.05 g), with a yield of 81.4%. 1 H NMR (500 MHz, DMSO-d6) δ 9.90 (d, J = 1.1 Hz, 1H), 7.12 (ddt, J =17.0, 2.4, 1.1 Hz, 2H), 6.89 (td, J = 2.4, 1.0 Hz, 1H), 5.24 (d, J = 1.0 Hz,2H), 3.80 (d, J = 1.2 Hz, 3H), 3.37 (d, J = 1.2 Hz, 3H). 18.2 Preparation of (E)-3-(3-methoxy-5-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one: ; Weigh 1-(3,4,5-tris(methoxymethoxy)phenyl)ethan-1-one (500 mg, 1.66 mmol) and 3-methoxy-5-(methoxymethoxy)benzaldehyde (326 mg, 1.66 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material reaction is complete. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-3-(3-methoxy-5-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one (561 mg) with a yield of 70.4%. 1HNMR (500 MHz, DMSO-d6) δ 7.77 (d, J = 15.6 Hz, 1H), 7.62 (d, J = 15.6 Hz, 1H), 7.53 (s, 2H), 7.10 (dt, J = 8.3, 1.6 Hz, 2H), 6.68 (t, J = 2.2 Hz, 1H), 5.31 (s, 4H), 5.23 (s, 2H), 5.16 (s, 2H), 3.79 (s, 3H), 3.51 (s, 3H), 3.42 (s, 6H), 3.38 (s, 3H). 13 C NMR (126 MHz, DMSO-d6) δ 188.42, 161.09, 158.53,150.94, 144.36, 141.16, 137.01, 133.57, 123.06, 110.77, 109.44, 108.29,104.99, 98.30, 95.34, 94.34, 57.03, 56.46, 56.18, 55.91. 18.3 Preparation of (E)-3-(3-hydroxy-5-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; Weigh (E)-3-(3-methoxy-5-(methoxymethoxy)phenyl)-1-(3,4,5-tri(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 0.836 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~ 1:1) to obtain a light yellow solid (E)-3-(3-hydroxy-5-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one (118 mg) with a yield of 46.7%. 1H NMR (500 MHz, DMSO-d6) δ 9.21 (s, 4H), 7.59 (d, J = 15.5 Hz, 1H), 7.45 (d, J = 15.4 Hz, 1H), 7.10 (s, 2H), 6.85 (s, 1H), 6.72 (s, 1H), 6.39 (s, 1H), 3.75 (s, 3H). 13 C NMR (126 MHz, DMSO-d6) δ 187.93,161.18, 159.15, 146.16, 143.02, 139.46, 137.17, 128.72, 122.78, 108.76,108.69, 104.90, 103.98, 55.66. Example 19 Preparation of (E)-3-(2-hydroxy-5-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; 19.1 Preparation of 5-methoxy-2-(methoxymethoxy)benzaldehyde: ; Weigh 2-hydroxy-5-methoxybenzaldehyde (1 g, 6.57 mmol), diisopropylethylamine (1.7 g, 13.15mmol), and anhydrous tetrahydrofuran (15 mL) in sequence. After stirring for 5 minutes under ice bath conditions, slowly add bromomethyl methyl ether (1.23 g, 9.86 mmol). React at room temperature for 2 hours, and monitor with TLC spot plate. The raw material reacts completely. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in sequence, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:30 ~1:4) to obtain 5-methoxy-2-(methoxymethoxy)benzaldehyde (867 mg), with a yield of 67.2%. 1 H NMR (500 MHz, DMSO-d6) δ 10.34 (s, 1H), 7.24-7.23 (m, 2H), 7.20-7.09(m, 1H), 5.26 (s, 2H), 3.74 (s, 3H), 3.41 (s, 3H). 19.2 Preparation of (E)-3-(5-methoxy-2-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one: ; Weigh 1-(3,4,5-tris(methoxymethoxy)phenyl)ethan-1-one (500 mg, 1.66 mmol) and 5-methoxy-2-(methoxymethoxy)benzaldehyde (326 mg, 1.66 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material reaction is complete. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-3-(5-methoxy-2-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one (409 mg) with a yield of 51.3%. 1 HNMR (500 MHz, DMSO-d6) δ 7.99 (d, J = 15.7 Hz, 1H), 7.82 (d, J = 15.7 Hz,1H), 7.53 (s, 2H), 7.49 (d, J = 3.1 Hz, 1H), 7.14 (d, J = 9.0 Hz, 1H), 7.02(dd, J = 9.0, 3.1 Hz, 1H), 5.31 (s, 4H), 5.23 (s, 2H), 5.16 (s, 2H), 3.78 (s,3H), 3.51 (s, 3H), 3.42 (s, 6H), 3.40 (s, 3H). 13 C NMR (126 MHz, DMSO-d6) δ188.48, 154.56, 150.98, 150.64, 141.02, 138.83, 133.75, 125.38, 123.01,118.09, 117.32, 113.57, 110.64, 98.29, 95.54, 95.33, 57.02, 56.44, 56.30,56.07. 19.3 Preparation of (E)-3-(2-hydroxy-5-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; Weigh (E)-3-(5-methoxy-2-(methoxymethoxy)phenyl)-1-(3,4,5-tri(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 0.836 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~ 1:1) to obtain a gray-black solid (E)-3-(2-hydroxy-5-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one (76 mg) with a yield of 30.1%. 1 H NMR (500 MHz, DMSO-d6) δ 9.71 (s, 1H), 9.22 (s,2H), 9.06 (s, 1H), 7.86 (d, J = 15.7 Hz, 1H), 7.69 (d, J = 15.7 Hz, 1H), 7.30(d, J = 2.6 Hz, 1H), 7.10 (s, 2H), 6.93-6.76 (m, 2H), 3.73 (s, 3H). 13 C NMR(126 MHz, DMSO-d6) δ 188.24, 152.73, 151.64, 146.12, 139.21, 138.41, 129.06,122.29, 121.94, 118.87, 117.51, 112.49, 108.59, 56.03. Example 20 Preparation of (E)-3-(2-hydroxy-3-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; 20.1 Preparation of 3-methoxy-2-(methoxymethoxy)benzaldehyde: ; Weigh 2-hydroxy-3-methoxybenzaldehyde (1 g, 6.57 mmol), diisopropylethylamine (1.7 g, 13.15 mmol), and anhydrous tetrahydrofuran (15 mL) in sequence. After stirring for 5 minutes under ice bath conditions, slowly add bromomethyl methyl ether (1.23 g, 9.86 mmol). React at room temperature for 2 hours, and monitor with TLC spot plate. The raw material reacts completely. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in sequence, and dry over anhydrous sodium sulfate. After vacuum spin drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:30 ~1:4) to obtain 3-methoxy-2-(methoxymethoxy)benzaldehyde (869 mg), with a yield of 67.2%. 1 H NMR (500 MHz, DMSO-d6) δ 10.34 (d, J = 1.0 Hz, 1H), 7.38 (dd, J =8.0, 1.6 Hz, 1H), 7.29 (dd, J = 7.8, 1.6 Hz, 1H), 7.22 (td, J = 7.9, 1.0 Hz,1H), 5.16 (d, J = 1.2 Hz, 2H), 3.84 (s, 3H), 3.45 (d, J = 1.2 Hz, 3H). 20.2 Preparation of (E)-3-(3-methoxy-2-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one: ; Weigh 1-(3,4,5-tris(methoxymethoxy)phenyl)ethan-1-one (500 mg, 1.66 mmol) and 3-methoxy-2-(methoxymethoxy)benzaldehyde (326 mg, 1.66 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material is completely reacted. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-3-(3-methoxy-2-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one (462 mg) with a yield of 58.0%. 1HNMR (500 MHz, DMSO-d6) δ 8.11 (d, J = 15.8 Hz, 1H), 7.79 (d, J = 15.8 Hz,1H), 7.60 (dd, J = 7.0, 2.4 Hz, 1H), 7.54 (s, 2H), 7.21-7.06 (m, 2H), 5.32(s, 4H), 5.16 (s, 2H), 5.10 (s, 2H), 3.81 (s, 3H), 3.51 (s, 3H), 3.46 (s,3H), 3.42 (d, J = 1.1 Hz, 6H). 13 C NMR (126 MHz, DMSO-d6) δ 188.30, 152.71,150.97, 145.68, 141.06, 139.26, 133.63, 129.29, 124.92, 122.89, 119.48,115.38, 110.60, 99.07, 98.29, 95.30, 57.63, 57.02, 56.44, 56.33. 20.3 Preparation of (E)-3-(2-hydroxy-3-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; Weigh (E)-3-(3-methoxy-2-(methoxymethoxy)phenyl)-1-(3,4,5-tri(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 0.836 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~ 1:1) to obtain a gray solid (E)-3-(2-hydroxy-3-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one (81 mg) with a yield of 32.1%. 1H NMR (500 MHz, DMSO-d6) δ 9.20 (s, 4H), 7.90 (d, J= 15.7 Hz, 1H), 7.65 (d, J = 15.7 Hz, 1H), 7.34 (dd, J = 8.0, 1.4 Hz, 1H), 7.08 (s, 2H), 6.99 (dd, J = 8.1, 1.4 Hz, 1H), 6.81 (t, J = 7.9 Hz, 1H), 3.81 (s, 3H). 13 C NMR (126 MHz, DMSO-d6) δ 188.19, 148.45, 146.76, 146.15, 139.24,138.31, 129.02, 122.33, 122.05, 120.52, 119.56, 113.69, 108.51, 56.43, 40.46,40.29, 40.12, 39.96, 39.79, 39.62, 39.46. Example 21 Preparation of (E)-3-(2-hydroxy-4-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; 21.1 Preparation of 4-methoxy-2-(methoxymethoxy)benzaldehyde: ; Weigh 2-hydroxy-4-methoxybenzaldehyde (1 g, 6.57 mmol), diisopropylethylamine (1.7 g, 13.15mmol), and anhydrous tetrahydrofuran (15 mL) in sequence. After stirring for 5 minutes under ice bath conditions, slowly add bromomethyl methyl ether (1.23 g, 9.86 mmol). React at room temperature for 2 hours, and monitor the TLC plate. The raw material reacts completely. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:30 ~1:4) to obtain 4-methoxy-2-(methoxymethoxy)benzaldehyde (850 mg), with a yield of 65.9%. 1H NMR (500 MHz, DMSO-d6) δ 10.21 (s, 1H), 7.67 (d, J = 8.7 Hz, 1H), 6.75 (s, 1H), 6.70 (dd, J = 8.7, 2.2 Hz, 2H), 5.35 (s, 2H), 3.82 (s, 3H),3.42 (s, 3H). 21.2 Preparation of (E)-3-(4-methoxy-2-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one: ; Weigh 1-(3,4,5-tris(methoxymethoxy)phenyl)ethan-1-one (500 mg, 1.66 mmol) and 4-methoxy-2-(methoxymethoxy)benzaldehyde (326 mg, 1.66 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material reacts completely. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-3-(4-methoxy-2-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one (425 mg) with a yield of 53.4%. 1 HNMR (500 MHz, DMSO-d6) δ 7.97 (d, J = 15.6 Hz, 1H), 7.89 (d, J = 8.7 Hz, 1H), 7.70 (d, J = 15.6 Hz, 1H), 7.50 (s, 2H), 6.74 (d, J = 2.4 Hz, 1H), 6.69 (dd,J = 8.7, 2.4 Hz, 1H), 5.34 (s, 2H), 5.30 (s, 4H), 5.15 (s, 2H), 3.80 (s, 3H), 3.51 (s, 3H), 3.42 (d, J = 1.8 Hz, 9H). 13C NMR (126 MHz, DMSO-d6) δ 188.25,163.11, 157.90, 150.95, 140.71, 139.19, 134.10, 130.82, 119.83, 117.25,110.36, 108.21, 101.58, 98.27, 95.29, 94.90, 57.02, 56.49, 56.43, 56.00. 21.3 Preparation of (E)-3-(2-hydroxy-4-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; Weigh (E)-3-(4-methoxy-2-(methoxymethoxy)phenyl)-1-(3,4,5-tri(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 0.836 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~ 1:1) to obtain a light yellow solid (E)-3-(2-hydroxy-4-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one (59 mg) with a yield of 23.4%. 1 H NMR (500 MHz, DMSO-d6) δ 10.29 (s, 1H), 9.16 (s, 3H), 7.81 (d, J = 15.7 Hz, 1H), 7.69-7.63 (m, 1H), 7.56 (d, J = 15.6 Hz, 1H), 7.04 (s, 2H), 6.46 (dd, J = 4.6, 2.3 Hz, 2H), 3.74 (s, 3H). 13 C NMR (126MHz, DMSO-d6) δ 188.13, 162.59, 159.09, 146.12, 146.09, 138.91, 138.78,131.95, 130.93, 129.34, 129.09, 119.16, 115.37, 108.34, 106.63, 101.58,65.46, 55.62. Example 22 Preparation of (E)-3-(3-hydroxy-4-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; 22.1 Preparation of 4-methoxy-3-(methoxymethoxy)benzaldehyde: ; Weigh 3-hydroxy-4-methoxybenzaldehyde (1 g, 6.57 mmol), diisopropylethylamine (1.7 g, 13.15 mmol), and anhydrous tetrahydrofuran (15 mL) in sequence. After stirring for 5 minutes under ice bath conditions, slowly add bromomethyl methyl ether (1.23 g, 9.86 mmol). React at room temperature for 2 hours, and monitor the TLC plate. The raw material reacts completely. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in sequence, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:30 ~1:4) to obtain 4-methoxy-3-(methoxymethoxy)benzaldehyde (1.1 g), with a yield of 85.3%. 1 H NMR (500 MHz, DMSO-d6) δ 9.81 (s, 1H), 7.60 (dd, J = 8.3, 1.9 Hz,1H), 7.52 (d, J = 1.9 Hz, 1H), 7.20 (d, J = 8.3 Hz, 1H), 5.22 (s, 2H), 3.87(s, 3H), 3.38(s, 3H). 22.2 Preparation of (E)-3-(4-methoxy-3-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one: ; Weigh 1-(3,4,5-tris(methoxymethoxy)phenyl)ethan-1-one (500 mg, 1.66 mmol) and 4-methoxy-3-(methoxymethoxy)benzaldehyde (326 mg, 1.66 mmol) and dissolve in 95% ethanol (10 mL). Slowly add 50% KOH solution (3 mL) under ice bath conditions and then naturally warm to room temperature for 3 hours. TLC spot plate monitoring shows that the raw material is completely reacted. Add ethyl acetate (100 mL), wash with water (50 mL X 3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:20 ~1:3) to obtain (E)-3-(4-methoxy-3-(methoxymethoxy)phenyl)-1-(3,4,5-tris(methoxymethoxy)phenyl)prop-2-en-1-one (582 mg) with a yield of 73.1%. 1 HNMR (500 MHz, DMSO-d6) δ 7.63 (d, J = 2.8 Hz, 2H), 7.57-7.49 (m, 4H), 7.08(d, J = 8.5 Hz, 1H), 5.31 (s, 4H), 5.22 (s, 2H), 5.15 (s, 2H), 3.83 (s, 3H), 3.51 (s, 3H), 3.42 (s, 6H), 3.41 (s, 3H). 13 C NMR (126 MHz, DMSO-d6) δ 188.26,152.84, 150.92, 146.26, 144.59, 140.91, 133.91, 127.81, 125.19, 120.30,117.37, 112.90, 110.65, 98.29, 95.42, 95.33, 57.03, 56.44, 56.33, 56.23. 22.3 Preparation of (E)-3-(3-hydroxy-4-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one: ; Weigh (E)-3-(4-methoxy-3-(methoxymethoxy)phenyl)-1-(3,4,5-tri(methoxymethoxy)phenyl)prop-2-en-1-one (400 mg, 0.836 mmol) and dissolve it in 95% ethanol (15 mL). Then add 10% HCl (3 mL) and react at 60°C for 2 hours. The reaction is complete when monitored by TLC. Add ethyl acetate (100 mL), wash with water (50 mL X3) and saturated brine (30 mL) in turn, and dry over anhydrous sodium sulfate. After vacuum drying, purify on a silica gel column (ethyl acetate: petroleum ether = 1:10 ~ 1:1) to obtain a yellow solid (E)-3-(3-hydroxy-4-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one (118 mg) with a yield of 46.7%. 1 H NMR (500 MHz, DMSO-d6) δ 9.15 (s, 4H), 7.58-7.38(m, 2H), 7.28-7.16 (m, 2H), 7.08 (s, 2H), 6.96 (d, J = 8.2 Hz, 1H), 3.81 (s,3H). 13 C NMR (126 MHz, DMSO-d6) δ 187.76, 150.41, 147.12, 146.13, 143.15,139.18, 129.02, 128.25, 121.98, 119.98, 114.85, 112.45, 108.50, 56.11. Experimental verification: The inhibitory activity of the chalcone compounds on xanthine oxidase in the above examples was determined by the following method: The amount of uric acid produced was measured using an ultraviolet spectrophotometer at a wavelength of 298 nm to evaluate the inhibitory activity of chalcone compounds on xanthine oxidase. The IC was calculated from the curve of the molar concentration of the compound-corresponding xanthine oxidase inhibition rate. 50 value.

[0021] result: Determine and calculate the IC of the chalcone compounds of the present invention respectively 50 The results are shown in Table 1.

[0022] Table 1. Inhibitory activity of chalcone compounds on xanthine oxidase

[0023] From the above table, it can be concluded that IC 50 The IC value of allopurinol in the prior art is used to evaluate the inhibitory activity of xanthine oxidase.50 The value is 12.3±0.2 μmol / L. The test results of Examples 1 to 22 are all better than this value. Among them, the IC value of the chalcone compound in Example 6 is 50 The lowest value was 0.047±0.002 μmol / L, and the corresponding compound was (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one, with the structural formula , compared with IC of Example 6 50 The value is slightly higher but still reaches 10 -2 Examples of Order of Magnitude (by IC 50 The values ​​are arranged from small to large) as follows: Example 19: 0.05±0.001 μmol / L, the corresponding compound is (E)-3-(2-hydroxy-5-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one, and its structural formula is .

[0024] Example 5: 0.059±0.0002 μmol / L, the corresponding compound is (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(2,4,6-trihydroxyphenyl)prop-2-en-1-one, and its structural formula is .

[0025] Example 16: 0.062±0.003 μmol / L, the corresponding compound is (E)-3-(2-hydroxy-6-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one, and its structural formula is .

[0026] The present invention does not elaborate on some of the common technologies of those skilled in the art. The above-described embodiments are only descriptions of preferred implementations of the present invention. The preferred embodiments do not describe all the details in detail, nor do they limit the invention to the specific implementations described. Without departing from the design spirit of the present invention, various modifications and improvements made by ordinary technicians in this field to the technical solution of the present invention should fall within the scope of protection determined by the claims of the present invention.

Claims

1. A chalcone compound suitable for treating hyperuricemia, characterized in that: The general structure is as follows: ; Wherein, R1 is hydrogen, hydroxyl or halogen; R2 is hydroxyl or hydrogen; R3 is hydroxy or hydrogen; R4 is hydroxyl or hydrogen; R5 is hydroxy or hydrogen; R6 is methoxy, hydroxy, halogen, methyl or hydrogen; R7 is methoxy, hydroxy or hydrogen; R8 is methoxy, hydroxy, cyano or hydrogen; R9 is hydroxy or hydrogen; R10 is methoxy, hydroxy or hydrogen.

2. The chalcone compound suitable for hyperuricemia according to claim 1, characterized in that: The chalcone compound is: (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(3-hydroxyphenyl)prop-2-en-1-one, and its structural formula is: ; Or (E)-1-(2-fluoro-4-hydroxyphenyl)-3-(4-hydroxy-2-methoxyphenyl)prop-2-en-1-one, whose structural formula is: ; Or (E)-1-(3,5-dihydroxyphenyl)-3-(4-hydroxy-2-methoxyphenyl)prop-2-en-1-one, the structural formula of which is: ; Or (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(2,3,4-trihydroxyphenyl)prop-2-en-1-one, the structural formula of which is: ; Or (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(2,4,6-trihydroxyphenyl)prop-2-en-1-one, the structural formula of which is: ; Or (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one, the structural formula of which is: ; Or (E)-3-(2-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one, the structural formula of which is: ; Or (E)-3-(4-hydroxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one, the structural formula of which is: ; Or (E)-3-(2,4-dimethoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one, the structural formula of which is: ; Or (E)-1-(3,4,5-trihydroxyphenyl)-3-(2,4,6-trimethoxyphenyl)prop-2-en-1-one, the structural formula of which is: ; Or (E)-3-(4-hydroxy-2-methylphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one, the structural formula of which is: ; Or (E)-3-(2-chloro-4-hydroxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one, the structural formula of which is: ; Or (E)-3-methoxy-4-(3-oxo-3-(3,4,5-trihydroxyphenyl)prop-1-en-1-yl)benzonitrile, the structural formula of which is: ; Or (E)-3-(3-hydroxy-2-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one, the structural formula of which is: ; Or (E)-3-(5-hydroxy-2-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one, the structural formula of which is: ; Or (E)-3-(2-hydroxy-6-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one, the structural formula of which is: ; Or (E)-3-(4-hydroxy-3-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one, the structural formula of which is: ; Or (E)-3-(3-hydroxy-5-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one, the structural formula of which is: ; Or (E)-3-(2-hydroxy-5-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one, the structural formula of which is: ; Or (E)-3-(2-hydroxy-3-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one, the structural formula of which is: ; Or (E)-3-(2-hydroxy-4-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one, the structural formula of which is: ; Or (E)-3-(3-hydroxy-4-methoxyphenyl)-1-(3,4,5-trihydroxyphenyl)prop-2-en-1-one, the structural formula of which is: 。 3. The method for preparing a chalcone compound suitable for hyperuricemia as claimed in claim 1 or 2, characterized in that: Step 1) Add an acetophenone derivative, a benzaldehyde derivative, 95% ethanol and 50% potassium hydroxide in an eggplant-shaped bottle in sequence, and stir the reaction at room temperature for 1-6 hours to cause a Claisen-Schmidt condensation reaction; after the reaction is complete as monitored by TLC, add ethyl acetate for extraction; then wash the ethyl acetate organic phase with water and saturated brine in sequence, dry it with anhydrous sodium sulfate, spin dry it under reduced pressure, and separate it by silica gel column chromatography to obtain a chalcone with a protecting group and a parent core of 1,3-diphenyl-2-propene-1-one; Step 2) Weigh the chalcone with a protecting group and a parent core of 1,3-diphenyl-2-propene-1-one obtained in step 1) respectively, dissolve it in 95% ethanol, add 10% dilute HCl, and react under heating conditions; after the reaction is completed by LCMS monitoring, first reduce the temperature of the reaction system to room temperature, then add water to dilute the reaction system and extract with ethyl acetate; then wash the ethyl acetate organic phase with water and saturated brine in sequence, dry it with anhydrous sodium sulfate, spin dry it under reduced pressure, and separate it by silica gel column chromatography to obtain a chalcone compound suitable for hyperuricemia.

4. Use of the chalcone compound suitable for hyperuricemia as claimed in claim 1 or 2 in the preparation of a drug for preventing and treating hyperuricemia or gout.

5. Use of the chalcone compound suitable for hyperuricemia as claimed in claim 4 in the preparation of a drug for preventing and treating hyperuricemia or gout, characterized in that: The IC values ​​of the chalcone compounds for xanthine oxidase 50 The values ​​ranged from 0.047±0.002μmol / L to 2.34±0.11μmol / L.

6. Use of the chalcone compounds as described in claim 1 or 2 in xanthine oxidase-related diseases, including but not limited to diseases related to xanthine oxidase overexpression such as lipid peroxidation, immune disorders, rheumatoid arthritis, heart failure, etc.

Citation Information

Cited By

  • Application of dihydrochalcone compounds in preparation of medicines for resisting skin pigmentation or reducing uric acid

    CN120983407A